Tarlatamab improves brain metastases control and survival compared to chemo in SCLC

Aspirin use linked to improved survival in endometrial cancer

miR371 shows promise as a surveillance biomarker for relapse in early-stage germ cell tumours

Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Lorlatinib delivers 7-year progression-free survival and durable brain control in ALK+ NSCLC

Low-dose pembrolizumab plus chemotherapy improves survival and expands access in advanced NSCLC

ASCO 2026: Latest updates in mRCC

Omission of axillary lymph node dissection reduces arm morbidity without compromising survival in select breast cancer cases

ASCO 2026: Breast cancer overview

mRNA-4359 plus pembrolizumab shows high response rates and robust T-cell activation in melanoma

Combination therapeutic strategies for aRCC patients with bone metastases